2 results match your criteria: "Hepatology Center Saiseikai Suita Hospital[Affiliation]"
Article Synopsis
- Researchers found that the Fibrosis-3 (FIB-3) index can accurately predict liver fibrosis progression in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), regardless of age.
- In a study of 1,398 patients, the FIB-3 index performed as well as the Fibrosis-4 (FIB-4) index for those under 60, but outperformed it for patients aged 60 and older.
- The FIB-3 index’s effectiveness suggests it could be a more reliable tool for assessing liver fibrosis than existing methods, enhancing diagnosis across different age groups.
Article Synopsis
- Researchers re-evaluated the modified NAFIC scoring system for diagnosing non-alcoholic steatohepatitis (NASH) in Japanese patients with non-alcoholic fatty liver disease (NAFLD), emphasizing the role of hyperinsulinemia.
- The study involved 147 NAFLD patients for initial scoring and an additional 355 patients for validation, assessing factors like fasting serum insulin levels and serum ferritin.
- Results indicated that the modified NAFIC score improved sensitivity and predictive value for NASH diagnosis, suggesting its potential as a useful clinical screening tool.